KMT2A and leukemia: Our studies indicate that EphA2 expression has no significant effect on the leukemogenic process in the MLL-AF9 mouse model and lack of EphA2 did not significantly affect leukemic disease latency, severity or leukemia stem cell (LSC) self-renewal.